Novra Announces $1.3 Million Private Placement

The proposed financing would make the Trust an Insider, with approximately 16.6% of Novra's outstanding shares after completion.

Rhea-AI Summary

Novra Technologies (NVRVF) has entered into a private placement agreement to receive $1,300,000 from The David E. Chymiak Trust dated December 15, 1999.

The non-brokered financing comprises 10,000,000 common shares at $0.13 per share, with no finder's fees or commissions. Novra plans to use the funding for working capital supporting new vertical and geographic markets, research and development, and repayment of existing liabilities. After completion, the Trust would hold approximately 16.6% of outstanding shares and become an Insider under TSX Policy 1.1. The proposed placement remains subject to TSX Venture Exchange approval, which has not yet been granted.

2 points · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major point. Forward-looking: it has not happened yet and may not happen.$1,300,000 proposed funding would support Novra's working capital and repayment of existing liabilities. 22% of market cap
• Minor pointNo finder's fees or commissions apply to the financing.

Negative

• Major point. Forward-looking: it has not happened yet and may not happen.10,000,000 new common shares at $0.13 each would dilute existing holders.
• Minor pointTSX Venture Exchange approval remains pending for the proposed private placement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Winnipeg, Manitoba--(Newsfile Corp. - October 28, 2026) - Novra Technologies Inc. (TSXV: NVI) ("Novra") is pleased to announce that it has entered into a private placement agreement under which it will receive $1,300,000 in funding. This funding will be used as additional working capital to support Novra's initiatives in new vertical and geographic markets, including support for Novra's research and development activities and to repay existing liabilities.

The agreement with The David E. Chymiak Trust dated December 15, 1999 (the "Trust") is a non-brokered private placement of 10,000,000 Novra common shares at $0.13 per share. No finder's fees or commissions apply to this financing. After completion of this private placement, the Trust will hold 10,000,000 shares, representing approximately 16.6% of Novra's issued and outstanding shares. As such the Trust will become an Insider of Novra as defined in TSX Policy 1.1.

This proposed private placement is subject to the approval of TSX Venture Exchange, which has not yet been granted.

About Novra Technologies Inc.:

Novra (TSXV: NVI) (OTCQB: NVRVF) is an international technology provider of products, systems and services for the distribution of multimedia broadband content. The Novra Group of companies includes Novra Technologies Inc, International Datacasting Corporation, and Wegener Corporation. The companies in the group are known for a strong focus on applications, including: broadcast video and radio, digital signage, highly reliable data distribution, government and defence, and other mission-focused applications. With R&D and manufacturing facilities in both Canada and the US, Novra Group serves prestigious customers around the world directly and in coordination with its extensive network of international resellers and partners.

For more information, visit: www.novragroup.com

Forward-Looking Statements:

This press release contains "forward-looking statements" within the meaning of applicable Canadian securities laws, concerning but not limited to: potential future transactions or anticipated developments in our operations in future periods. Forward-looking statements are generally identifiable by words such as "expect", "anticipate", "believe", "intend", "estimate", "predict", "outlook", "opportunity", "momentum", "potential", "proposed", "targeted", "plans" "possible", "positive indication for", "looking forward to", "commitment to", "is starting to", and similar expressions, or statements that events, conditions or results "will", "may", "could" or "should" occur or be achieved. As such, forward-looking statements are not historical facts but reflect our current assumptions and expectations regarding future events. These are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations and assumptions. Some of these risks and uncertainties are described under the "Risks and Uncertainties" section of Novra's MD&A.

For the above reasons, readers are cautioned not to place undue reliance on forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

# # #

CONTACT FOR NOVRA:

Harris Liontas
CEO
+1 204 989 4632
hliontas@novra.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/321475

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the terms of Novra's $1.3 million private placement?

Novra's non-brokered private placement would issue 10,000,000 common shares at $0.13 per share to The David E. Chymiak Trust dated December 15, 1999, for $1,300,000 in funding. No finder's fees or commissions apply.

Has Novra's private placement received TSX Venture Exchange approval?

TSX Venture Exchange approval has not yet been granted. The proposed private placement is subject to that approval.